Login to View
StrategyR is a trade mark of Global Industry Analysts, Inc. USA
A trade mark of Global Industry Analysts, Inc.


Label-Free Detection

A Global Strategic Business Report

MCP12916


CURRENT DATA STACK: 0

Executive Citations

|

Company Discussions

|

Brand/Product Insights

LOADING COMPANIES....
Data Room - StrategyR.com

INFLUENCERS# 46,275

<
RESEARCH TRANSCRIPTS
Towards a high-throughput label-free detection system combining localized-surface plasmon...
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Video related to Communication appearing in Lab on a Chip. Y. Zhang et al, "Towards a high-throughput label-free detection system combining localized-surface plasmon resonance and microfluidics". Read the article at http://xlink.rsc.org/?doi=10.1039/C2LC40590C

TRANSCRIPT:

Agilent Technologies - Intro to 802.11ac technology and testing
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Presentation by Colville Crooks.

TRANSCRIPT:

A Stock | Agilent Technologies Q4 2020 Earnings Call
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Access earnings conference call transcripts at: https://news.alphastreet.com/earnings-call-transcripts/ Earnings Calendar: https://news.alphastreet.com/earnings-calendar/ Earnings Infographics: https://news.alphastreet.com/infographics/ Listen on: https://podcasts.apple.com/us/podcast/the-earnings-podcast-from-alphastreet/id1535892241?uo=4 https://anchor.fm/earningspodcast/ https://open.spotify.com/show/67gyUX6kl1lpewQcWDvHJ0 https://podcasts.google.com/feed/aHR0cHM6Ly9hbmNob3IuZm0vcy8zODY2ZmUwOC9wb2RjYXN0L3Jzcw== https://radiopublic.com/the-earnings-podcast-from-alphast-Gq2Bpo Follow us on: https://twitter.com/AlphSt_Live https://twitter.com/_AlphaStreet https://www.facebook.com/AlphaStreetinc https://www.linkedin.com/company/alphastreet http://www.google.com/news/s/CAowj7D0Cg https://apple.news/TZOi1Q735Ty-T4dxalibGNw Subscribe this channel to listen to earnings call audios

TRANSCRIPT:

A Stock | Agilent Technologies Inc. Q3 2020 Earnings Call
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Agilent Technologies Inc. Q3 2020 Earnings Conference Call Transcript https://news.alphastreet.com/earnings-call-transcripts/

TRANSCRIPT:

Industry Insights with Thermo Fisher Scientific
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

This session with guest speakers from Thermo Fisher Scientific covers the diverse range of careers available with the company from science, sales, IT and finance. Hear from a panel of professionals working in the sector sharing information about their role, career progression and what they expect from students looking to apply for Thermo Fisher Scientific graduate roles.

TRANSCRIPT:

BIO KOREA 2019 - BIO PR(Patheon, by Thermo Fisher Scientific)
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Successful outsourcing strategies for the development and manufacturing of biologics -Patheon, by Thermo Fisher Scientific More and more companies are looking for a CDMO partner to advance their molecule into Phase I clinical trials as quickly as possible. Patheon’s Quick to Clinic program can deliver released drug substance (IgG1 or IgG4) starting from DNA in just 14 months. This is 6 months faster than most other standard timelines and includes a cell line documentation package, non-GMP drug substance for toxicology studies, released GMP drug substance for First-in-Human studies, viral clearance data and at least one month of stability data. Although speed is important, a strong quality track record, flexibility, and technical expertise should also be key attributes of your selected CDMO. Molecule formats such as Fc-fusions, bispecific antibodies, and non-antibody recombinant proteins are becoming more popular but can be challenging to develop. Patheon has expertise with these molecule types and can apply many of the Quick to Clinic strategies to identify suitable manufacturing processes ASAP.

TRANSCRIPT:

Thermo Fisher Scientific Lebanon Ribbon Cutting August 2022
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

This is the official opening of the BioProduction Single-Use Technology Lebanon, TN site. The 400,000-square-foot facility enables us to help meet rapidly growing demand of bioprocessing materials to produce vaccines and breakthrough therapies for cancer and other diseases.

TRANSCRIPT:

Thermo Fisher Scientific Pte Ltd
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Reliable Analysis of Ethylene Oxide and 2-chloroethanol in Food Samples using Gas Chromatography Mass Spectrometry

TRANSCRIPT:

Thermo Fisher Scientific Supporting Atma Nirbhar Bharat
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Applied Biosystems CoviPath COVID-19 RT-PCR Kit is approved for in vitro diagnostic use by the Indian Council for Medical Research (ICMR) and Drug Control General of India (DCGI)

TRANSCRIPT:

Thermo Fisher Scientific CEO on 2023 outlook for business in China
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Cramer spoke with Thermo Fisher Scientific CEO Marc Casper on Wednesday. Sign up and learn more about the CNBC Investing Club with Jim Cramer https://cnb.cx/3Ei22n4 » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. Connect with CNBC News Online Get the latest news: http://www.cnbc.com/ Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC https://www.cnbc.com/select/best-credit-cards/ #CNBC #CNBCTV

TRANSCRIPT:

Thermo Fisher Scientific CEO: Expanding in Emerging Markets | Mad Money | CNBC
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Jim Cramer chats with Thermo Fisher Scientific CEO Marc Casper about the rise of individualized medicine and where he sees the biotech industry is headed. » Subscribe to CNBC: http://cnb.cx/SubscribeCNBC » Watch more Mad Money here: http://bit.ly/WatchMadMoney » Read more about Thermo Fisher Scientific here: https://cnb.cx/2HGCQgu "Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Cramer is your personal guide through the confusing jungle of Wall Street investing, navigating through both opportunities and pitfalls with one goal in mind -- to try to help you make money. About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more. Get More Mad Money! Read the latest news: http://madmoney.cnbc.com Watch full episodes: http://bit.ly/MadMoneyEpisodes Follow Mad Money on Twitter: http://bit.ly/MadMoneyTwitter Like Mad Money on Facebook: http://bit.ly/LikeMadMoney Follow Cramer on Twitter: http://bit.ly/FollowCramer Connect with CNBC News Online! Visit CNBC.com: http://www.cnbc.com/ Find CNBC News on Facebook: http://cnb.cx/LikeCNBC Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC Follow CNBC News on Google+: http://cnb.cx/PlusCNBC Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC Thermo Fisher Scientific CEO: Expanding in Emerging Markets | Mad Money | CNBC

TRANSCRIPT:

Amit Chopra, CMD and VP/GM, India and South Asia, Thermo Fisher Scientific, Mumbai
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Amit Chopra, CMD and VP/GM, India and South Asia, Thermo Fisher Scientific, Mumbai reveals how CoviPath is different from other kits available in market.

TRANSCRIPT:

Thermo Fisher scientific And Its Growth In India | Part-1|
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

In an exclusive chat with Nano TV, the Asia Pacific head of Thermo Fisher Scientific draws plans for Indian markets and sees great potential for its product offerings in India. Watch for this exclusive industry talk on Nano TV. Watch this series only on Nano TV The Science Channel. facebook: https://www.facebook.com/nanodigest2009/ Linkedin : https://www.linkedin.com/in/nano-digest-254795185/

TRANSCRIPT:

Ken Kapur| Thermo Fisher Scientific | USA | Industrial Engineering 2014 | OMICS International
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Title: How do you turn compliance into an opportunity? RoHs & REACH environmental regulations International Summit on Industrial Engineering December 08-10, San Francisco, USA OMICS International: http://conferenceseries.com/ OMICS open access Journals: http://omicsonline.org Global Medical Conferences: http://conferenceseries.com Global Pharmaceutical Conferences: http://pharmaceuticalconferences.com Global Cancer Conferences: http://cancersummit.org Global Diabetes Conferences: http://diabetesexpo.com Global Dental Conferences: http://dentalcongress.com Global Nursing Conferences: http://nursingconference.com Abstract Due to end of life concerns with electronics and the impact to human health and the environment, new product environmental regulations are rapidly becoming a challenge for electronics manufacturers. Based on the European RoHS and REACH requirements, it is imperative that manufacturers successfully comply with product environmental regulations in a timely manner. However, the real value is not just to comply, but to fully integrate these requirements into business processes and take advantage of new opportunities. Strategies for successful compliance will be discussed to turn compliance into an opportunity. The RoHS regulations target the removal of the six banned substances. RoHS was originally released in the European Union, but similar requirements have expanded globally. Throughout the supply chain, the substances shall be removed such that end products can be compliant.The REACH SVHC requirements target over 150 substances. New obligations have been set up to identify, communicate and phase out these substances. Based on detailed research of these restricted substances, these substances can be readily found in the supply chain. Communication is required throughout the electronics industry to identify usage and phase out restricted substances. This presentation will look at the complete product life cycle but will focus on the impacts of restricted substances. Opportunities to integrate the requirements into business processes will be covered along with optimizing systems. Biography Ken Kapur is leading the Global Compliance Engineering Group at Thermo Fisher Scientific LSG Division as an Associate Director; he is currently responsible for Product certification of Instruments at Thermo Fisher. He has an extensive background with over 25 years in Product Compliance. He has an Electrical Engineering Degree from the University of the Pacific and started his work in the area of product safety. He has expanded his expertise to cover a wide range of compliance requirements from Product Safety to Environmental Compliance. He has been invited to speak at a number of forums on various regulatory compliance topics globally.

TRANSCRIPT:

Thermo Fisher Scientific Biopharma Summit - San Diego
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Do you know which technologies are at the forefront of biotherapeutic characterization? The Biopharma Summit events, being held worldwide by Thermo Fisher Scientific, present a valuable opportunity for scientists to get together, share insight, and face the challenges of biopharma characterization together. Example topics include complete glycan characterization workflows, advanced fragmentation strategies, and breakthroughs in data management. Why attend the Biopharma Summit? Charles Olea, Analytical Chemist & Chemical Biologist at Ajinomotoe Althea, says, “The more heads in the room the better. Someone is going to know something that you don’t know, or you might know something that they don’t know.” Find out what other attendees thought of previous BioPharma Summit events, and their key takeaways, in this beautiful video from San Diego. --------------------- Read more of our articles here: https://themedicinemaker.com/ Sign up for free digital & physical copies here: https://themedicinemaker.com/login/sign-up This film was created by Texere Video Production. To find out more visit our website. To discuss your own video needs contact our team at video@texerepublishing.com Subscribe to The Medicine Maker official YouTube channel here: https://bit.ly/3aXH6EP Press the bell button to receive notifications whenever we post a new video. Follow us and access our latest content: Twitter: https://bit.ly/3C3coWV Facebook: https://bit.ly/3vBcBye Linkedin: https://bit.ly/3vKTulr Instagram: https://bit.ly/3jlzOPK Website: https://bit.ly/30MUQR8 To follow what we are doing at Texere follow us: Twitter: https://bit.ly/3nfDZ0P Facebook: https://bit.ly/3AZ9fWI Linkedin: https://bit.ly/3b1ZHj6 Instagram: https://bit.ly/3E8BoMO Website: https://bit.ly/3B51GxG

TRANSCRIPT:

Clinical and Commercial Manufacturing at Thermo Fisher Scientific, Brisbane
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Thermo Fisher Scientific's Brisbane, Australia site is 2014 winner of the ISPE Facility of the Year award and 2015 winner of the Frost and Sullivan APAC CMO of the year award. The site provides scale up and manufacturing services of recombinant proteins and monoclonal antibodies. ---------------- Read more of our articles here: https://themedicinemaker.com/ Sign up for free digital & physical copies here: https://themedicinemaker.com/login/sign-up This film was created by Texere Video Production. To find out more visit our website. To discuss your own video needs contact our team at video@texerepublishing.com Subscribe to The Medicine Maker official YouTube channel here: https://bit.ly/3aXH6EP Press the bell button to receive notifications whenever we post a new video. Follow us and access our latest content: Twitter: https://bit.ly/3C3coWV Facebook: https://bit.ly/3vBcBye Linkedin: https://bit.ly/3vKTulr Instagram: https://bit.ly/3jlzOPK Website: https://bit.ly/30MUQR8 To follow what we are doing at Texere follow us: Twitter: https://bit.ly/3nfDZ0P Facebook: https://bit.ly/3AZ9fWI Linkedin: https://bit.ly/3b1ZHj6 Instagram: https://bit.ly/3E8BoMO Website: https://bit.ly/3B51GxG

TRANSCRIPT:

Thermo Fisher Scientific: 05/15/20
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Chris Langsdorf: Studying the immune response to viral infection with flow cytometry

TRANSCRIPT:

Thermo Fisher Scientific at the 2018 Tech Challenge
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

Volunteers from Thermo Fisher Scientific promote STEM for kids at the 2018 Tech Challenge at the San Jose Tech Museum

TRANSCRIPT:

Thermo Fisher Scientific: Biobanking & Cryopreservation
LOW OKAY GOOD GREAT
0

MY SILO

DESCRIPTION:

The Thermo Scientific™ 2D-Barcode tubes offer a fast workflow with high sample integrity for optimal usage in biobanking processes. No matter if you need a simple system for your small lab or a complex high-tech solution for laboratory automization processes, we offer the right 2D-code tubes for you. Thermo Scientific™ tubes provide tracking, sample safety, high visibility and optimal performance when it comes to biobanking and cryo storage.

TRANSCRIPT: